Article info
PDFWhat neurologists need to
Patent foramen ovale
- Correspondence to Dr Vafa Alakbarzade, Royal Cornwall Hospitals NHS Trust, Truro TR1 3LQ, UK; vafa.alakbarzade.10{at}ucl.ac.uk
Citation
Patent foramen ovale
Publication history
- Accepted March 1, 2020
- First published April 16, 2020.
Online issue publication
June 02, 2020
Article Versions
- Previous version (2 June 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Diagnosis and management of patent foramen ovale
- Patent foramen ovale and ventricular septal defect closure
- Advances in the management of cardioembolic stroke associated with patent foramen ovale
- Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism
- Indications for the closure of patent foramen ovale
- Patent foramen ovale: the current state of play
- Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism
- Stroke and migraine: a cardiologist’s headache
- Persistence of residual shunt at 6 and 12 months after transoesophageal echocardiography-guided percutaneous closure of a patent foramen ovale for cryptogenic stroke
- Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy